š ANS Biotech is pleased to announce its participation in the upcoming BIO International Convention, taking place from June 16 to 19, 2025, at the Boston Convention and Exhibition Center (USA).
This globally recognized event, organized by the Biotechnology Innovation Organization, gathers over 15,000 biotech and pharma leaders from around the world for four days of high-level networking, business development, and thought leadership.
š¹ Julie Chamalet (Business Developer) and Yassine Darbaky (Chief Business Officer) will proudly represent ANS Biotech during the event.
As a CRO exclusively focused on preclinical pain pharmacology, ANS Biotech brings a deep and proven expertise in in vivo models, tailored preclinical profiling strategies, and innovative platforms such as ALGOGramā¢, all designed to accelerate the development of effective pain therapies.
š If you are looking to discuss strategic partnerships or explore how our specialized services can support your analgesic pipeline, meetings can be scheduled via the official BIO One-on-One Partneringā¢ platform or at the French Pavilion #1935.
Letās connect in Boston to shape the future of pain research together.
š A special thanks to the Auvergne-RhĆ“ne-Alpes Region for its support in making this international presence possible.
š BIO International Convention 2025
šļø June 16ā19, 2025
š Boston, Massachusetts, USA
šā Schedule a meeting via BIO Partneringā¢
š¤Meet directly our Team at the French Pavilion #1935